Biocoral, Inc. - OTCOB: BCRA
Biocoral, Inc. is an international company specializing in research & development and commercialization of biomaterials, biomedical technologies and biotechnologies .
Via its French subsidiaries, the company researches, develops, manufactures and markets bone graft (Biocoral®) and other bone growth products for orthopedic, oral and maxillofacial applications to a number of countries outside the United States.
The company has also developed what the management believes is the world's first fully autologous biological glue.
The company has also completed the final stages of development of its product for treatment of bone fractures associated to osteoporosis and is continuing to work on prevention of such fractures. Biocoral, Inc. is a Delaware corporation incorporated in 1992 that entered the biomaterials field in 1995.
The Company common stock is quoted on the OTCQB Markets under the symbol BCRA.